A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

NCT00749632 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence, Urge

Interventions

DRUG: oxybutynin
DRUG: oxybutynin
DRUG: oxybutynin

Sponsor

FemmePharma Global Healthcare, Inc.